GUJTHEM — Gujarat Themis Biosyn Income Statement
0.000.00%
Last trade - 00:00- IN₹36.46bn
- IN₹36.63bn
- IN₹1.51bn
Annual income statement for Gujarat Themis Biosyn, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 906 | 1,149 | 1,490 | 1,698 | 1,508 |
| Cost of Revenue | |||||
| Gross Profit | 752 | 982 | 918 | 1,017 | 923 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 520 | 590 | 773 | 946 | 873 |
| Operating Profit | 386 | 558 | 716 | 752 | 635 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 409 | 590 | 775 | 793 | 655 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 302 | 436 | 580 | 592 | 488 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 302 | 436 | 580 | 592 | 488 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 302 | 436 | 580 | 592 | 488 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.77 | 4 | 5.32 | 5.43 | 4.48 |
| Dividends per Share |